|
2024
|
Invention
|
Novel sulfonamide derivatives having selective nox inhibiting activity.
A compound of formula (I... |
|
|
Invention
|
Gel formulation for topical ocular use. A gel formulation for ocular topical use, comprising a co... |
|
2023
|
G/S
|
DIETETIC FOODS ADAPTED FOR MEDICAL USE FOR INVALID PATIENTS; DIETETIC FOODS ADAPTED FOR MEDICAL U... |
|
|
G/S
|
Dietetic foods adapted for invalids; dietetic foods for use
in clinical nutrition; dietetic subs... |
|
2019
|
Invention
|
Sulfonamide derivatives having selective nox inhibiting activity. A compound of formula (I) or a ... |
|
|
Invention
|
Novel sulfonamide derivatives having selective nox inhibiting activity. A compound of formula (I)... |
|
2016
|
Invention
|
2-(3,4-dimethylphenyl)-6-((4-(p-tolyl)piperazin-1-yl)methyl)-1,3,5-triazine-2,4-diamine. 2-(3,4-d... |
|
|
Invention
|
N2-(3,4-dimethylphenyl)-6-((4-(p-tolyl)piperazin-1-yl)methyl)-1,3,5-triazine-2,4-diamine. The com... |
|
2015
|
Invention
|
Compounds for use in the treatment of conditions associated with nadph oxidase. A compound of for... |
|
2013
|
Invention
|
Triazine derivatives for the treatment of conditions associated with nicotinamide adenine dinucle... |
|
|
Invention
|
Compounds for use in therapy.
A compound of formula (I)
A compound of formula (I)
A comp... |
|
|
Invention
|
Thiophene- based compounds exhibiting nox4 inhibitory activity and use thereof in therapy. A comp... |
|
|
Invention
|
Thiophene-based compounds exhibiting nox4 inhibitory activity and use thereof in therapy. A compo... |
|
2007
|
Invention
|
The use of naphtoquinones in the treatment and control of diabetes, insulin resistance and hyperg... |
